Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
7.55
1.16
15.36%
Share Warrants & Outstandings
Total Reserve
5.54
25.58
-20.04
-78.34%
Shareholder's Funds
14.25
33.13
-18.88
-56.99%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.21
2.57
0.64
24.90%
Secured Loans
0.66
1.23
-0.57
-46.34%
Unsecured Loans
2.55
1.33
1.22
91.73%
Deferred Tax Assets / Liabilities
-0.08
-0.17
0.09
52.94%
Other Long Term Liabilities
1.04
0.03
1.01
3,366.67%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.43
2.42
0.01
0.41%
Current Liabilities
Trade Payables
1.85
31.89
-30.04
-94.20%
Other Current Liabilities
2.56
12.66
-10.10
-79.78%
Short Term Borrowings
7.70
13.94
-6.24
-44.76%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
12.11
58.48
-46.37
-79.29%
Total Liabilities
28.79
94.03
-65.24
-69.38%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.76
5.17
-1.41
-27.27%
Less: Accumulated Depreciation
1.06
2.55
-1.49
-58.43%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.71
2.62
0.09
3.44%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
0.00
0.03
0.00%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
3.74
-3.74
-100.00%
Total Non-Current Assets
2.75
6.36
-3.61
-56.76%
Current Assets Loans & Advances
Current Investments
0.00
1.67
-1.67
-100.00%
Inventories
6.21
4.67
1.54
32.98%
Sundry Debtors
16.13
54.62
-38.49
-70.47%
Cash and Bank
0.59
3.11
-2.52
-81.03%
Other Current Assets
1.13
2.06
-0.93
-45.15%
Short Term Loans and Advances
1.98
21.55
-19.57
-90.81%
Total Current Assets
26.05
87.67
-61.62
-70.29%
Net Current Assets (Including Current Investments)
13.93
29.19
-15.26
-52.28%
Total Current Assets Excluding Current Investments
26.05
86.00
-59.95
-69.71%
Miscellaneous Expenses not written off
0.00
0.22
-0.22
-100.00%
Total Assets
28.79
94.03
-65.24
-69.38%
Contingent Liabilities
3.37
0.00
3.37
0.00%
Total Debt
7.41
16.51
-9.10
-55.12%
Book Value per share (adjusted)
18.03
43.90
-25.87
-58.93%
Annual - Borrowings
Borrowings 9.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 26.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
